Dr. Kenneth Stuart Stoller, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1755 Dix Hwy, Lincoln Park, MI 48146 Phone: 313-382-9650 Fax: 313-382-3428 |
Pearle Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2031 Dix Hwy, Lincoln Park, MI 48146 Phone: 313-388-6280 Fax: 313-388-6538 |
Dr. Teoman Altay Ermete, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1755 Dix Hwy, Lincoln Park, MI 48146 Phone: 313-382-9650 Fax: 313-382-3428 |
Dr. Stephen Jeffery Rope, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2100 Southfield Rd, Lincoln Park, MI 48146 Phone: 313-389-3190 Fax: 313-389-3099 |
Elizabeth Irwin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2100 Southfield Rd, Lincoln Park, MI 48146 Phone: 313-382-8044 Fax: 313-389-3099 |
Eye Care Optometry Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1755 Dix Hwy, Lincoln Park, MI 48146 Phone: 313-382-9650 Fax: 313-382-0723 |
Dr. Joseph Anthony Montana, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1755 Dix Hwy, Lincoln Park, MI 48146 Phone: 313-382-9650 Fax: 313-382-3428 |
News Archive
Scientists at Michigan State University have discovered a new kind of stem cell, one that could lead to advances in regenerative medicine as well as offer new ways to study birth defects and other reproductive problems.
University of Queensland researchers have developed biosensors that use nanoengineered porous gold which more effectively detect early signs of disease, potentially improving patient outcomes.
Doctors and clinical investigators from the throughout the Middle East gathered today in Dubai for the opening of the International Osteoporosis Foundation's (IOF) 1st Middle-East and Africa Osteoporosis Meeting.
TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today released the following open letter to shareholders reviewing the highlights of 2009 and providing an overview of the Company's strategic plan and outlook for 2010.
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that it will be presenting three separate presentations at the Cambridge Healthtech Institute's 4th Annual Antibacterial Drug Development Conference, Resistance is Futile: The Challenge of Antibacterial Drug Development, April 27 - 28, in San Diego, CA.
› Verified 1 days ago